Stay updated on Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial page
- Check4 days agoChange DetectedA site-wide notice about NIH website changes appears above the ClinicalTrials.gov 403 error page. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked.SummaryDifference0.5%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with an access-denied message.SummaryDifference19%

- Check39 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0, signaling a software update rather than a change to the study details. The update likely includes backend or UI improvements without altering the displayed study information.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now displays a new revision tag, v3.6.6, replacing the previous v3.6.5. This indicates a minor software version or publishing update rather than changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial page.